Center for Responsive Politics, October 2, 2015. Soaring drug prices already had customers unhappy. The pharmaceutical industry hardly needed a new poster boy to add volume and passion to the complaints.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Pharmaceutical Industry, Under Scrutiny for Prices, Has History of Big Political Wins
Center for Responsive Politics, October 2, 2015. Soaring drug prices already had customers unhappy. The pharmaceutical industry hardly needed a new poster boy to add volume and passion to the complaints.
Read More »Investigation: Advisory Panel Suggests Limited Use of Popular Contraceptive Essure
WCBD NEWS 2, September 29, 2015. An advisory panel is now recommending limited use of the popular birth control Essure until more is known about its safety. The advisory panel suggests women with an allergy to metal, an autoimmune disease or history of pelvic inflammatory disease stay away from Essure right now.
Read More »The ‘Safe’ Birth Control That Wasn’t
The Daily Beast, September 24, 2014. After participating in clinical trials for Essure, a contraceptive implant, several women complained of severe pain and bleeding—but they say their trial records were altered.
Read More »FDA Panel Weighs Complaints on Essure Contraceptive Implant
The New York Times, September 24, 2015. A panel of experts convened by the Food and Drug Administration excoriated the manufacturer of a contraceptive device for not collecting data that they say could have helped predict risks for women. The device has received thousands of complaints from women who say they were harmed by it.
Read More »